文献速递脑血管病外科神经重症

岩尖部硬脑膜动静脉瘘

Dural Arteriovenous Fistulas at the Petrous Apex.
PubMed 文献 · World Neurosurg · 2018-08-10

回顾15年间64例连续岩尖部硬脑膜动静脉瘘患者,按血管构筑分为三型。症状以非出血性神经功能缺损为主(82.8%),蛛网膜下腔出血占12.5%。并发症发生率为14.1%,包括短暂性脑神经麻痹、再出血和呼吸衰竭。作者认为该分型可反映临床特征并为治疗提供建议。

要点

  • 岩尖部硬脑膜动静脉瘘按静脉扩张情况分为I型(无静脉扩张,48.4%)、II型(静脉扩张但瘘口近端静脉正常,29.7%)和III型(瘘口处静脉扩张,21.9%)。
  • I型患者96.77%表现为非出血性神经功能缺损,77.42%为幕下引流;II型和III型蛛网膜下腔出血更常见(21.05%和28.57%),多伴幕上引流(63.16%和85.71%)。
  • 并发症发生9例(14.1%),包括短暂性脑神经麻痹(4.7%)、再出血(6.3%)和呼吸衰竭(3.1%);再出血率I型0%、II型10.53%、III型14.29%。

核心结论

  • 岩尖部硬脑膜动静脉瘘具有较高的栓塞相关并发症风险。
  • 基于血管构筑的分型可能反映其临床特征,并为岩尖部硬脑膜动静脉瘘的治疗提供一些建议。

研究设计与样本

  • 回顾性分析15年间64例连续岩尖部硬脑膜动静脉瘘患者,按血管构筑分为I型(无静脉扩张,48.4%)、II型(静脉扩张但瘘口近端静脉正常,29.7%)和III型(瘘口处静脉扩张,21.9%)。

主要发现

  • 共纳入53例男性和11例女性;症状为蛛网膜下腔出血8例(12.5%)、非出血性神经功能缺损53例(82.8%)、无症状3例(4.7%)。
  • 治疗方式:经动脉栓塞49例、显微手术8例、栓塞联合显微手术7例。
  • 并发症9例(14.1%),包括短暂性脑神经麻痹(4.7%)、再出血(6.3%)和呼吸衰竭(3.1%)。
  • I型患者96.77%表现为非出血性神经功能缺损,77.42%为幕下引流;II型21.05%、III型28.57%发生蛛网膜下腔出血,多数为幕上引流(分别为63.16%和85.71%)。
  • 不同分型中栓塞联合显微手术的需求(I型6.45%、II型10.53%、III型21.43%)和再出血并发症发生率(I型0%、II型10.53%、III型14.29%)存在差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Dural arteriovenous fistulas (DAVFs) at the petrous apex are rare but may cause subarachnoid hemorrhage (SAH) or severe brainstem edema. This study aimed to summarize their clinical features and discuss the classification. METHODS: During a 15-year period, 64 consecutive patients with DAVF at the petrous apex were reviewed. According to their angioarchitecture, these cases were classified as follows: type I, no venous ectasia (48.4%); type II, venous ectasia but with normal vein proximal to the fistula (29.7%); and type III, venous ectasia at the site of the fistula (21.9%). RESULTS: There were 53 men and 11 women included. Presented symptoms were SAH in 8 patients (12.5%), nonhemorrhagic neurologic defects (NHNDs) in 53 patients (82.8%), and no symptoms in 3 patients (4.7%). There were 49 patients who received transarterial embolization, 8 patients who received microsurgery, and 7 patients who received embolization and microsurgery. Complications occurred in 9 patients (14.1%), including transient cranial nerve palsy (4.7%), rebleeding (6.3%), and respiratory failure (3.1%). Of the type I patients, 96.77% presented with NHNDs and 77.42% presented with infratentorial drainage. However, SAH occurred more often in type II (21.05%)/type III cases (28.57%), and most patients carried a supratentorial drainage (63.16% and 85.71%, respectively). In different types of DAVFs, the necessity for embolization combined with microsurgery (6.45% in type I, 10.53% in type II, 21.43% in type III) and the occurrence of rebleeding complications (0% in type I, 10.53% in type II, and 14.29% in type III) were varied. CONCLUSIONS: Petrous apex DAVFs carried a high risk of embolization-related complications. Based on the vascular architecture, this classification may reflect their clinical features and provide some advice on the treatment of DAVFs at the petrous apex.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Li J, Ren J, Du S, et al. Dural Arteriovenous Fistulas at the Petrous Apex. World Neurosurg. 2018. PMID: 30103057. doi:10.1016/j.wneu.2018.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。